Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Extinct Human Fossil’s Complete Genome Decoded

By LabMedica International staff writers
Posted on 21 Feb 2012
German scientists have completed the entire genome sequence of a Denisovan, a relative of an Asian group of extinct humans related to Neandertals.

In 2010, Dr. More...
Svante Pääbo, from the Max Planck Institute for Evolutionary Anthropology (Leipzig, Germany), and his colleagues presented a draft version of the genome from a small fragment of a human finger bone discovered in Denisova Cave in southern Siberia. The DNA sequences showed that this individual came from an earlier unknown group of extinct humans that have become known as Denisovans. Together with their sister group the Neandertals, Denisovans are the closest extinct relatives of currently living humans.

The Leipzig team has now developed sensitive novel techniques, which have allowed them to sequence every position in the Denisovan genome about 30 times over, using DNA extracted from less than 10 milligrams of the finger bone. In an earlier draft version published in 2010, each position in the genome was determined, on average, only twice. This degree of resolution was enough to establish the relationship of Denisovans to Neandertals and modern-day humans, but frequently made it impossible for researchers to study the evolution of specific parts of the genome. The now-completed version of the genome allows even the small differences between the copies of genes that this individual inherited from its mother and father to be differentiated.

On February 8, 2012, the Leipzig group made the entire Denisovan genome sequence available to researchers over the internet. “The genome is of very high quality,” said Matthias Meyer, who developed the techniques that made this technical feat possible. “We cover all nonrepetitive DNA sequences in the Denisovan genome so many times that it has fewer errors than most genomes from present-day humans that have been determined to date.”

The genome represents the first high-coverage, complete genome sequence of an archaic human group--a huge advance in the study of extinct forms of humans. “We hope that biologists will be able to use this genome to discover genetic changes that were important for the development of modern human culture and technology, and enabled modern humans to leave Africa and rapidly spread around the world, starting around 100,000 years ago,” said Dr. Pääbo.

The genome is also expected to reveal new aspects of the history of Denisovans and Neandertals. The scientists plan to present an article describing the genome later in 2012. “But we want to make it freely available to everybody already now,” said Dr. Pääbo. “We believe that many scientists will find it useful in their research.”

The project is made possible by funding from the Max Planck Society and is part of efforts since almost 30 years by Dr. Pääbo’s group to study ancient DNA. The finger bone was found by Prof. Anatoly Derevianko and Prof. Mikhail Shunkov, from the Russian Academy of Sciences (Moscow) in 2008 during their excavations at Denisova Cave, a unique archeological site that contains cultural layers indicating that human occupation at the site began up to 280,000 years ago. The finger bone was found in a layer that has been dated to between 50,000 and 30,000 years ago.

The genome is available as a Public Data Set via Amazon Web Services (AWS) as well as at the Max Planck Website (please see Related Links below).

Related Links:

Max Planck Institute for Evolutionary Anthropology
Denisovan Genome at Max Planck
Public AWS Dataset




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.